To date, the molecular basis of pulmonary fibrosis has been poorly understood. Scientists have now shown that reduced activity of the transcription factor FoxO3 plays a key role in the development of the disease. In research on mice, the progress of the disease was able to be halted using drugs that boost FoxO3 activity. The researchers are hoping they may have found a possible approach to treatment.
from Top Health News – ScienceDaily http://bit.ly/2lfXaHF
from Tumblr http://bit.ly/2Di0vh4
No comments:
Post a Comment